Cipla wins patent case against Roche; stk hits 52-week high

Roche had filed the suit in 2008 against Cipla on drug Tarceva.
 
Cipla touched a 52-week high of Rs 387.25. At 11:22 hrs the share was quoting at Rs 385.85, up Rs 5.20, or 1.37%.

Also Read - Cipla wins patent case against Roche

It was trading with volumes of 15,261 shares. In the previous trading session, the share closed up 1.56% or Rs 5.85 at Rs 380.65.

The company's trailing 12-month (TTM) EPS was at Rs 12.05 per share. (Jun, 2012). The stock's price-to-earnings (P/E) ratio was 32.02. The latest book value of the company is Rs 93.92 per share. At current value, the price-to-book value of the company was 4.11. The dividend yield of the company was 0.52%.